Recommended Clinical Study Design for Ventricular Tachycardia Ablation From Food and Drug Administration (FDA) 🇺🇸 A guidance document outlining the recommended study design for ventricular tachycardia ablation in clinical settings. Metadata quality: Metadata quality: Data description filled Files documentation missing License filled Update frequency not followed File formats are closed Temporal coverage filled Spatial coverage filled All files are available Learn more about this indicator Metadata quality: 66.66666666666666/100 Updated on March 18, 2020 Other (Public Domain) 0 reuses 0 favorites
